TMO — candidate.roundup
Update
TMO — candidate.roundup
Reason: TMO stays the cleanest structure and just got more extended — RSI 71.5, +35.17% over three months, only -0.92% off its high, with no dated news behind the move. MRNA is the real story of the week: +25.06% on top of an already extreme run, now +606.13% on the year, a magnitude this desk still cannot source to any filing. CRSP added +6.8% on a generic bump in sentiment, still -8.23% on the year. AMGN (+7.9%) and VRTX (+0.6%) were quieter. Roster unchanged.
Price/RSI Table
| Stock | Price | 7D | 30D | 52wkHi | 1Y | vs 200-day | RSI | Status | Action |
|---|---|---|---|---|---|---|---|---|---|
| MRNA | $182.11 | +25.06% | +31.12% | -5.3% | +606.13% | +191.1% | 71.9 | 🟠 Extended | ⚠️ Don't chase |
| TMO | $665.30 | +2.6% | +5.81% | -0.92% | +41.63% | +23.4% | 71.5 | 🟠 Extended | ⚠️ Don't chase |
| AMGN | $406.09 | +7.9% | -8.51% | -9.16% | +41.59% | +12.4% | 51.9 | 🟢 Pullback in trend | 📈 Accumulate |
| VRTX | $516.34 | +0.6% | -5.71% | -7.84% | +35.98% | +9.6% | 46.8 | 🟢 Pullback in trend | 📈 Accumulate |
| CRSP | $55.76 | +6.8% | -2.31% | -28.95% | -8.23% | +4.5% | 51.2 | 🟢 Pullback in trend | 🔍 Watch |
Status reads the 200-day trend first and RSI second; Action is a trend-hold lens — an extended name is never an entry, and a name below its 200-day with a negative year is not a dip.
What Changed Since 2026-09-18
- TMO's RSI moved from 67.6 to 71.5 with +35.17% over three months and only -0.92% off its high — the desk's cleanest structure is now also its most extended. Its news pull (last refreshed September 18) returns the same second-quarter earnings recap already on file; nothing new is dated to this week.
- MRNA +25.06% on the week on top of an already extraordinary run — now +606.13% on the year. Its pull (refreshed September 22) resurfaces recaps of the already-known Q2 print; the size of this move has no receipt behind it. Read the annual figure with real caution.
- CRSP +6.8% on the week; a September 22 portal summary credits CASGEVY commercial momentum and pipeline optimism, unconfirmed by any filing on file. Still -8.23% on the year at alpha -24.
- AMGN +7.9% on the week; its pull (refreshed September 22) returns nothing newer than September 10 items (analyst price-target moves), so news was not pulled for this week's specific gain.
- VRTX +0.6%; its news file remains stale since April 14 — a failed pull, not evidence of no news.
- Roster unchanged: no entrants, no dropouts. Nothing new for these names sits in the desk's event record this week.
Sources
- Tape data (price, RSI, returns, one-year change and alpha, distance to the 200-day): pre-computed summaries as of the 2026-09-23 close — biotech (Schwab). AMGN from biotech-scan (tracked outside the core biotech list).
- Prior edition (format and roster only): 2026-09-18-biotech.
- News checks: latest,
.../CRSP/news/latest.json,.../AMGN/news/latest.json(all pulled 2026-09-22),.../TMO/news/latest.json(pulled 2026-09-18),.../VRTX/news/latest.json(failed, stale since 2026-04-14).
Related
10 events DateTypeEvent
Sep 23 ScanBiotech Scan Sep 25 UpdateTMO — candidate.roundup Sep 25 ScanBiotech Scan Sep 18 UpdateTMO — candidate.roundup Sep 18 ScanBiotech Scan Oct 2 UpdateMRNA — candidate.roundup Oct 2 ScanBiotech Scan Sep 11 ScanBiotech Scan Oct 9 UpdateMRNA — candidate.roundup Oct 9 ScanBiotech Scan No direct external sources are attached to this read.